FACULTY

Michael Aberman
Michael Aberman

Vice President, Strategy and Investor Relations
REGENERON

Richard Anders
Richard Anders

Founder
MASS MEDICAL ANGELS

Estuardo Aguilar
Estuardo Aguilar

CEO
ADVANTAGENE

Michael Bailey
Michael Bailey

CEO
AVEO ONCOLOGY

Roy Baynes
Roy Baynes

Senior Vice President, Head of Clinical Development
MERCK

Jeremy Bender
Jeremy Bender

COO
TIZONA THERAPEUTICS

Lewis Bender
Lewis Bender

CEO
INTENSITY THERAPEUTICS

Donald Bergstrom
Donald Bergstrom

CMO
MERSANA THERAPEUTICS

Carl Berke
Carl Berke

Partner
PARTNERS HEALTHCARE VENTURES

Kevin Bitterman
Kevin Bitterman

Partner
POLARIS PARTNERS

Steve Brannan
Steve Brannan

CMO
KARUNA PHARMACEUTICALS

Richard Brudnick
Richard Brudnick

Executive Vice President, Business Development
BIOVERATIV

David Brush
David Brush

Senior Director, Transactions
JOHNSON & JOHNSON

Christine Carberry
Christine Carberry

COO
KERYX BIOPHARMACEUTICALS

Gail Cawkwell
Gail Cawkwell

CMO
PURDUE PHARMACEUTICALS

Jesse Cedarbaum, Vice President, Clinical Development, BIOGEN
Jesse Cedarbaum

Vice President, Clinical Development
BIOGEN

Jeremy Chadwick, Vice President and Head, Global Clinical Development Operations, SHIRE
Jeremy Chadwick

Vice President and Head, Global Clinical Development Operations
SHIRE

Josh Cohen
Josh Cohen

CEO
AMYLYX PHARMACEUTICALS

Ron Cohen, CEO, ACORDA THERAPEUTICS
Ron Cohen

CEO
ACORDA THERAPEUTICS

Michael Cola, CEO, AEVI GENOMIC MEDICINE
Michael Cola

CEO
AEVI GENOMIC MEDICINE

Laurence Cooper, CEO, ZIOPHARM
Laurence Cooper

CEO
ZIOPHARM

Heather DeBenedetto, Vice President, Head of Therapeutic Operations, MODERNA THERAPEUTICS
Heather DeBenedetto

Vice President, Head of Therapeutic Operations
MODERNA THERAPEUTICS

Deborah Dunsire, Principal, SOUTHERN CROSS BIO
Deborah Dunsire

Principal
SOUTHERN CROSS BIO

Neal Farber, CEO, NEUROHEALING PHARMACEUTICALS
Neal Farber

CEO
NEUROHEALING PHARMACEUTICALS

Maria Fardis, CEO, LION BIOTECHNOLOGIES
Maria Fardis

CEO
LION BIOTECHNOLOGIES

Maurizio Fava, Director, Division of Clinical Research, MGH RESEARCH INSTITUTE
Maurizio Fava

Director, Division of Clinical Research
MGH RESEARCH INSTITUTE

Mitchell Finer, CEO, ONCORUS
Mitchell Finer

CEO
ONCORUS

Greg Fiore, CMO, SYNEDGEN
Greg Fiore

CMO
SYNEDGEN

Dennis Ford, CEO, LIFE SCIENCE NATION
Dennis Ford

CEO
LIFE SCIENCE NATION

Karen Gardner, Senior Director, Clinical Development Operations, SEQIRUS
Karen Gardner

Senior Director, Clinical Development Operations
SEQIRUS

Angus Grant, Vice President, Regulatory Affairs, Finance, CELGENE
Angus Grant

Vice President, Regulatory Affairs, Finance
CELGENE

Carolyn Green, Executive Director, Strategic Investments, Worldwide R&D, PFIZER
Carolyn Green

Executive Director, Strategic Investments, Worldwide R&D
PFIZER

Luba Greenwood, Vice President, Global Mergers, Acquisitions and Business  Development, ROCHE
Luba Greenwood

Vice President, Global Mergers, Acquisitions and Business Development
ROCHE

Richard Gregory, CSO, IMMUNOGEN
Richard Gregory

CSO
IMMUNOGEN

Jessica Grossman, CEO, MEDICINES360
Jessica Grossman

CEO
MEDICINES360

Mike Hale, Vice President and Head of Biostatistics and Programming, SHIRE
Mike Hale

Vice President and Head of Biostatistics and Programming
SHIRE

Scott Harris, CMO, LYRIC PHARMACEUTICALS
Scott Harris

CMO
LYRIC PHARMACEUTICALS

Dana Hilt, CMO, LYSOSOMAL THERAPEUTICS
Dana Hilt

CMO
LYSOSOMAL THERAPEUTICS

John Hohneker,  Executive Vice President, Head of R&D, FORMA THERAPEUTICS
John Hohneker

Executive Vice President, Head of R&D
FORMA THERAPEUTICS

Lan Huang, CEO, BEYONDSPRING PHARMACEUTICALS
Lan Huang

CEO
BEYONDSPRING PHARMACEUTICALS

Martin Huber, CMO, TESARO
Martin Huber

CMO
TESARO

Stephen Isaacs, CEO, ADURO BIOTECH
Stephen Isaacs

CEO
ADURO BIOTECH

Eva Jack, CBO, MERSANA THERAPEUTICS
Eva Jack

CBO
MERSANA THERAPEUTICS

Kenneth Kaitin, Director, TUFTS CENTER FOR THE STUDY OF DRUG  DEVELOPMENT
Kenneth Kaitin

Director
TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT

Edward Kaye, CEO, SAREPTA THERAPEUTICS
Edward Kaye

CEO
SAREPTA THERAPEUTICS

Justin Klee, President, AMYLYX PHARMACEUTICALS
Justin Klee

President
AMYLYX PHARMACEUTICALS

Isaac Kohane, Chair, Department of Biomedical Informatics, HARVARD MEDICAL  SCHOOL
Isaac Kohane

Chair, Department of Biomedical Informatics
HARVARD MEDICAL SCHOOL

William Korinek, CEO, ASTROCYTE PHARMACEUTICALS
William Korinek

CEO
ASTROCYTE PHARMACEUTICALS

Pablo Lapuerta, Executive Vice President and CMO, LEXICON PHARMACEUTICALS
Pablo Lapuerta

Executive Vice President and CMO
LEXICON PHARMACEUTICALS

John Lee, CMO, PHASEBIO PHARMACEUTICALS
John Lee

CMO
PHASEBIO PHARMACEUTICALS
 

Liz Lewis, Chief Counsel, Head of Patient Advocacy, TAKEDA ONCOLOGY
Liz Lewis

Chief Counsel, Head of Patient Advocacy
TAKEDA

Casey Logan, CBO, TRACON PHARMACEUTICALS
Casey Logan

CBO
TRACON PHARMACEUTICALS

Timothy Lowinger, CSO, MERSANA THERAPEUTICS
Timothy Lowinger

CSO
MERSANA THERAPEUTICS

David Loynd, CEO, ENDURX PHARMACEUTICALS
David Loynd

CEO
ENDURX PHARMACEUTICALS

Krishna Menon, CSO and President of Research, CELLCEUTIX
Krishna Menon

CSO and President of Research
CELLCEUTIX

Michael Metzger, President and COO, SYNDAX
Michael Metzger

President and COO
SYNDAX

Ramon Mohanlal, CMO, BEYONDSPRING PHARMACEUTICALS
Ramon Mohanlal

CMO
BEYONDSPRING PHARMACEUTICALS

Jodie Morrison, CEO, TOKAI PHARMACEUTICALS
Jodie Morrison

CEO
TOKAI PHARMACEUTICALS

Rich Murray, CEO, JOUNCE THERAPEUTICS
Rich Murray

CEO
JOUNCE THERAPEUTICS

Shakti Narayan, Vice President, Head of Transactions, JOHNSON & JOHNSON
Shakti Narayan

Vice President, Head of Transactions
JOHNSON & JOHNSON

Melissa Nelson, Senior Global Project Manager, MEDTRONIC
Melissa Nelson

Senior Global Project Manager
MEDTRONIC

Sara Nochur,  Senior Vice President, Regulatory Affairs, ALNYLAM PHARMACEUTICALS
Sara Nochur

Senior Vice President, Regulatory Affairs
ALNYLAM PHARMACEUTICALS

Denis Patrick, Executive Director, Head, External R&D Innovation, PFIZER
Denis Patrick

Executive Director, Head, External R&D Innovation
PFIZER

Matt Portch, Vice President, Managed Markets, SUNOVION
Matt Portch

Vice President, Managed Markets
SUNOVION

Amit Rakhit, CMO, OVID THERAPEUTICS
Amit Rakhit

CMO
OVID THERAPEUTICS

Chandra Ramanathan, Vice President and Head, East Coast Innovation Center,  BAYER
Chandra Ramanathan

Vice President and Head, East Coast Innovation Center
BAYER

Rosemary Reilly, Partner, WILMER HALE
Rosemary Reilly

Partner
WILMER HALE
 

Katie Reilly-Gauvin, Vice President, Global Commercial Development, ABBVIE
Katie Reilly-Gauvin

Vice President, Global Commercial Development
ABBVIE

Jane Rhodes, Senior Director, New Innovations, BIOGEN
Jane Rhodes

Senior Director, New Innovations
BIOGEN

Lindsay Rosenwald, CEO, FORTRESS BIOTECH
Lindsay Rosenwald

CEO
FORTRESS BIOTECH

Natalie Sacks, CMO, ADURO BIOTECH
Natalie Sacks

CMO
ADURO BIOTECH

Tehseen Salimi, Vice President, Medical Affairs, TREVENA
Tehseen Salimi

Vice President, Medical Affairs
TREVENA

Cynthia Schwalm, President, North American Commercial Operations, IPSEN
Cynthia Schwalm

President, North American Commercial Operations
IPSEN

Rob Scott, CMO, ABBVIE
Rob Scott

CMO
ABBVIE

David Sherris, CEO, GENADAM THERAPEUTICS,
David Sherris

CEO
GENADAM THERAPEUTICS

Neal Simon, CEO, AZEVAN PHARMACEUTICALS
Neal Simon 

CEO 
AZEVAN PHARMACEUTICALS

David Soergel, CMO, TREVENA
David Soergel

CMO
TREVENA

Andrew Storey, Vice President, Global Regulatory Strategy, ABBVIE
Andrew Storey

Vice President, Global Regulatory Strategy
ABBVIE

P.K. Tandon, Senior Vice President, Biometrics & Development Strategy, ULTRAGENYX
P.K. Tandon

Senior Vice President, Biometrics & Development Strategy
ULTRAGENYX

Steve Targum, CMO, FUNCTIONAL NEUROMODULATION
Steve Targum

CMO
FUNCTIONAL NEUROMODULATION

Charles Theuer, CEO, TRACON PHARMACEUTICALS
Charles Theuer

CEO
TRACON PHARMACEUTICALS

Doug Treco, CEO, RA PHARMACEUTICALS
Doug Treco

CEO
RA PHARMACEUTICALS

Nancy Valente, Vice President, Global Product Development, GENENTECH
Nancy Valente

Vice President, Global Product Development
GENENTECH
 

Maria Vilenchik, CEO, FELICITEX THERAPEUTICS
Maria Vilenchik

CEO
FELICITEX THERAPEUTICS

Sue Washer, CEO, APPLIED GENETIC TECHNOLOGIES CORPORATION
Sue Washer

CEO
APPLIED GENETIC TECHNOLOGIES CORPORATION

Jeff Wiezorek, Senior Vice President, Clinical Development, KITE PHARMA
Jeff Wiezorek

Senior Vice President, Clinical Development
KITE PHARMA

Keith Wilcoxen, Senior Director, Scientific R&D, TESARO
Keith Wilcoxen

Senior Director, Scientific R&D
TESARO

Leslie Williams, CEO, IMMUSANT
Leslie Williams

CEO
IMMUSANT

Bryon Wornson, Vice President, Global Health and Value, PFIZER
Bryon Wornson

Vice President, Global Health and Value
PFIZER

Andrew-Young
Andrew Young

CSO
INTARCIA THERAPEUTICS 

Steven-Zelenkofske
Steven Zelenkofske

Vice President, Cardiovascular Medical Affairs, Therapeutic Area Head
ASTRAZENECA